Population Screening Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Population Screening Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $37.93 billion In 2028 At A CAGR Of 6.8%.

The population screening market size has grown strongly in recent years. It will grow from $27.02 billion in 2023 to $29.12 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to disease prevention initiative, government health policies, rising healthcare costs, increased disease awareness.

The population screening market size is expected to see strong growth in the next few years. It will grow to $37.93 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to shift towards personalized medicine, aging population and chronic diseases, integration of ai and data analytics, expansion of screening access. Major trends in the forecast period include advancements in medical technology, genomics and precision screening, telehealth and remote screening, multi-disease screening panels, health equity and accessibility, .

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12587&type=smp

Population Screening Market Major Segments
The population screening market covered in this report is segmented -

1) By Product: Hardware Equipment, Testing Or Lab, Analytics Or Interpretation
2) By Gender: Male, Female
3) By Age: Ages Less Than 15, 15-65, Ages 65 And Above
4) By Business: Hospitals, Research Institutes, Diagnostic Labs

Key Driver - The Surge Of Population Screening In Addressing The Growing Cancer Burden

The rising prevalence of cancer is expected to propel the growth of the population screening market going forward. Cancer is a condition in which specific cells in the human body develop inappropriately and spread to other parts of the human organism. Population screening can help detect cancer early when it is more treatable and has a better prognosis. For instance, according to the American Cancer Society, a US-based voluntary health organization, around 1.96 million new cancer cases are expected to be diagnosed in the US in 2023, an increase from approximately 1.9 million new cases that occurred in 2021. Therefore, the rising prevalence of cancer is driving the growth of the population screening market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12587&type=smp

Prominent Trend - The Technological Renaissance In Population Screening Markets

Technological advancements are the key trend gaining popularity in the population screening market. Major companies operating in the population screening market are adopting new technologies to sustain their position in the market. For instance, in May 2021, Evoq Technologies LLC, a US-based company developing innovative technologies for healthcare and biotechnology research, launched SmartERG, the first phone-based retinal health testing platform. This device works to gather data about retinal health by flashing a regulated light at the eye and collecting an electrical and physiological response from the retina. Based on a delay or reduction in visual responses, it can identify retinal diseases that may develop to cause vision loss or blindness. It provides cloud services with strong AI (artificial intelligence) and machine learning support, easy patient-provider linkages, and ophthalmic care.

Population Screening Market Players
Major companies operating in the population screening market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Sonic Healthcare Limited, Illumina Inc., SYNLAB International GmbH, Quidel Corporation, Bio-Rad Laboratories Inc., Unilabs, Qiagen N.V., Exact Sciences Corporation, ARUP Laboratories Inc., LGC Limited, OPKO Health Inc., Natera Inc., Cerba HealthCare S.A.S, Invitae Corp, Amedes Holding GmbH, Grail, Luminex Corporation, Novogene Co. Ltd., Trinity Biotech, Gene by Gene Ltd., Innova Medical Group Inc., Evoq Technologies LLC, LabPLUS

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/population-screening-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the population screening market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the population screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Population Screening Market Report Structure
3. Population Screening Market Trends And Strategies
4. Population Screening Market - Macro Economic Scenario
5. Population Screening Market Size And Growth
…..
27. Population Screening Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.